| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $700K | -50.6% |
| Cost of Revenue | $11.9M | +506.9% |
| R&D Expense | $20.8M | -27.2% |
| SG&A Expense | $14.0M | -26.8% |
| Operating Income | -$58.1M | +7.9% |
| Pre-tax Income | -$58.5M | +8.1% |
| Income Tax | $0 | — |
| Net Income | -$58.5M | +8.1% |
| EPS (Basic) | -$1.72 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.1M | +113.7% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $0 | -100.0% |
| Current Assets | $62.1M | +69.7% |
| Total Assets | $77.9M | +43.6% |
| Current Liabilities | $6.0M | -29.8% |
| Total Liabilities | $80.1M | +331.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.0M | +13.1% |
| Capital Expenditures | $401K | -8.2% |
| Investing Cash Flow | -$401K | -105.3% |
| Financing Cash Flow | $79.9M | +27.5% |
| Free Cash Flow | -$47.4M | +13.1% |
| +24.6% |
| Stockholders' Equity |
| -$2.2M |
| -106.3% |